MDS Panel near me in Asansol

A Myelodysplastic Syndromes (MDS) panel by Next-Generation Sequencing (NGS) is a genetic test that utilizes NGS technology to analyze a specific set of genes associated with MDS. This panel typically includes genes involved in hematopoiesis and hematologic malignancies, such as DNMT3A, ASXL1, TET2, SF3B1, and others. By sequencing these genes, the test can identify mutations and genetic abnormalities that contribute to the development of MDS. The results aid in diagnosis, risk stratification, and treatment planning for individuals with MDS, allowing for more personalized and targeted care.